Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of the most common diseases in the world affecting up to 40 percent of U.S. adults.
Liver cells have a vital metabolic inflexibility during regeneration to starve dysfunctional cells and keep damage from spreading, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Science.
July 28 marks World Hepatitis Day, a date dedicated to raising awareness about hepatitis and promoting measures to combat this serious public health issue.
The July issue of The American Journal of Gastroenterology includes an updated clinical guideline on focal liver lesions, which are increasingly common findings in abdominal imaging.
A new study from Keck Medicine of USC published in The American Journal of Gastroenterology finds that transgender adults have double the prevalence of cirrhosis compared to cisgender adults (people whose gender identity matches the sex they were assigned at birth), suggesting a need for more supportive, preventive care.
More clinical research is needed to investigate how reducing alcohol consumption in patients with alcohol-related liver disease (ALD) may slow disease progression and improve outcomes, according to an international task force of experts from more than two dozen institutions including UT Southwestern Medical Center.
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds. The research findings will be presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass and published in Nature’s npj Gut and Liver.
Cedars-Sinai digestive and liver diseases physicians and scientists will share their latest research at the annual Digestive Disease Week meeting, that takes place May 18-21, in Washington, D.C.
A groundbreaking multicenter cohort study in China has illuminated the impact of sex on the outcomes of liver transplantation (LT) for hepatocellular carcinoma (HCC), the most common type of liver cancer.
The May issue of The American Journal of Gastroenterology highlights new clinical science and reviews on hepatic encephalopathy management using a smartphone app’s artificial intelligence, cyclic vomiting syndrome prevalence and incidence, alcohol-associated liver disease and alcohol use disorder in young women, and polypectomy technique.
Interdisciplinary researchers in Illinois, the U.S. and around the world can advance their projects with the Beckman Institute for Advanced Science and Technology's new Zeiss Xradia 630 Versa micro-CT scanner, the first of its kind with life science applications in the U.S.
In a new study, Saint Louis University School of Medicine researchers and colleagues have identified biomarkers in high-risk infants with alpha-1 antitrypsin deficiency (AATD). This is a condition that is life-threatening in some infants but very mild in others. For the first time, predicting which children need lifesaving intervention is possible.
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children’s Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).
Hackensack Meridian Jersey Shore University Medical Center welcomed Lee F. Peng, M.D., PhD, as section chief of gastroenterology, department of medicine.
Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.
Patients diagnosed with steatotic liver disease (formerly called fatty liver disease) are usually advised to stop drinking alcoholic beverages. But a new study led by Cedars-Sinai found that drinking, on average, a small amount of alcohol a day did not lead to further liver damage in patients with mild disease.
A world-first analysis of a sudden global outbreak of hepatitis in children finds although the primary suspect is highly likely to be an infection by multiple viruses, many questions still puzzle researchers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
